Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

60275 1492790397HCLSReviewGreeceApril2017.pdf
Energy Boardroom

NICE proposes U-turn on Novartis's Glivec for GIST

27.06.2014 /

Bayer/Onyx Pharmaceuticals Stivarga (regorafenib) is approved for the treatment of GIST in the US, but a European filing in this indication is currently under review.

LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: